Literature DB >> 30888533

The usefulness of three-dimensional video-assisted thoracoscopic esophagectomy in esophageal cancer patients.

Kotaro Yamashita1, Shinji Mine2, Tasuku Toihata1, Ian Fukudome1, Akihiko Okamura1, Masami Yuda1, Masaru Hayami1, Yu Imamura1, Masayuki Watanabe1.   

Abstract

BACKGROUND: The three-dimensional video-assisted (3D-VA) system is known to provide depth perception and the precise measurement of anatomical spaces, unlike the two-dimensional video-assisted (2D-VA) system. However, the advantages of the 3D-VA system in thoracoscopic esophagectomy remains unclear.
METHODS: We retrospectively analyzed data from 104 patients who underwent thoracoscopic esophagectomy for esophageal cancer from 2016 to 2017. We performed thoracic esophagectomy using either the 2D-VA or 3D-VA system during this period. Whenever the 3D-VA system was available in our surgical center, we performed 3D-VA thoracoscopic esophagectomy. Perioperative parameters, including operation times, blood loss, the number of dissected lymph nodes, postoperative complications, and the duration of postoperative hospital stays, were compared between the 2D-VA and 3D-VA system groups.
RESULTS: There were 51 and 53 patients in the 2D-VA and 3D-VA system groups, respectively. Preoperative parameters, including age, sex, tumor location, clinical stage and the distribution of preoperative treatment, were not significantly different between the groups. Although intraoperative blood loss did not differ between the two groups, operation times were significantly shorter in the 3D-VA system group than the 2D-VA system group (P = 0.023). The number of dissected mediastinal lymph nodes was similar in both groups. The incidences of postoperative complications, including pneumonia, recurrent nerve palsy, anastomotic leakages and chylothorax, were similar between the groups. The duration of postoperative hospital stays was also comparable between the groups.
CONCLUSIONS: An introduction of 3D-VA endoscopy into minimally invasive esophagectomies may contribute to the shortening of the duration of thoracoscopic procedures.

Entities:  

Keywords:  Esophageal cancer; Thoracoscopic esophagectomy; Three-dimensional video-assisted system

Year:  2019        PMID: 30888533     DOI: 10.1007/s10388-019-00661-4

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  20 in total

1.  Three-dimensional Laparoscopy: Does Improved Visualization Decrease the Learning Curve Among Trainees in Advanced Procedures?

Authors:  Kyle G Cologne; Joerg Zehetner; Loriel Liwanag; Christian Cash; Anthony J Senagore; John C Lipham
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2015-08       Impact factor: 1.719

2.  Three-dimensional (3D) simulation versus two-dimensional (2D) enhances surgical skills acquisition in standardised laparoscopic tasks: a before and after study.

Authors:  A Ashraf; D Collins; M Whelan; R O'Sullivan; P Balfe
Journal:  Int J Surg       Date:  2015-01-02       Impact factor: 6.071

3.  3D visualization reduces operating time when compared to high-definition 2D in laparoscopic liver resection: a case-matched study.

Authors:  Vimalraj Velayutham; David Fuks; Takeo Nomi; Yoshikuni Kawaguchi; Brice Gayet
Journal:  Surg Endosc       Date:  2015-03-25       Impact factor: 4.584

4.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Authors:  A Herskovic; K Martz; M al-Sarraf; L Leichman; J Brindle; V Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

5.  Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.

Authors:  Christophe Mariette; Laetitia Dahan; Françoise Mornex; Emilie Maillard; Pascal-Alexandre Thomas; Bernard Meunier; Valérie Boige; Denis Pezet; William B Robb; Valérie Le Brun-Ly; Jean-François Bosset; Jean-Yves Mabrut; Jean-Pierre Triboulet; Laurent Bedenne; Jean-François Seitz
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

6.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

7.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

8.  3-Dimensional (3D) laparoscopy improves operating time in small spaces without impact on hemodynamics and psychomental stress parameters of the surgeon.

Authors:  Xiaoyan Feng; Anna Morandi; Martin Boehne; Tawan Imvised; Benno M Ure; M Ure Benno; Joachim F Kuebler; Martin Lacher
Journal:  Surg Endosc       Date:  2015-02-12       Impact factor: 4.584

9.  A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database.

Authors:  Hiroya Takeuchi; Hiroaki Miyata; Mitsukazu Gotoh; Yuko Kitagawa; Hideo Baba; Wataru Kimura; Naohiro Tomita; Tohru Nakagoe; Mitsuo Shimada; Kenichi Sugihara; Masaki Mori
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  3 in total

1.  Prevention of intra-thoracic recurrent laryngeal nerve injury with robot-assisted esophagectomy.

Authors:  Kei Hosoda; Masahiro Niihara; Hideki Ushiku; Hiroki Harada; Mikiko Sakuraya; Marie Washio; Keishi Yamashita; Naoki Hiki
Journal:  Langenbecks Arch Surg       Date:  2020-06-03       Impact factor: 3.445

2.  Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma.

Authors:  Zibin Liang; Xiaojian Li; Bingjiang Huang; Haiyan Shi; Xiaohua Gong; Jing Yu; Caixia Xiao; Bin Zhou
Journal:  J Gastrointest Oncol       Date:  2021-10

3.  Three-dimension versus two-dimension video-assisted thoracoscopic surgery for esophageal cancer: a meta-analysis.

Authors:  Ning Xin; Xinyu Ding; Kenan Huang; Rongqiang Wei; Zihao Chen; Chengdong Liu; Yunhao Fang; Zhifei Xu; Hua Tang
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.